Related Experiment Video

Updated: Aug 30, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

The natural history of chronic hepatitis B: a retrospective study

Gui-Cheng Wu1, Wei-Ping Zhou, You-Rong Zhao

  • 1Department of Digestive Diseases, Chongqing Three Gorges Central Hospital, Wanzhou District, Chongqing 404000, China.

Hepatobiliary & Pancreatic Diseases International : HBPD INT
|November 25, 2003
PubMed

Insights

Chronic hepatitis B patients face poor long-term outcomes, with significantly higher rates of cirrhosis, liver cancer, and death compared to controls. Further research is needed to determine the effectiveness of antiviral drugs in managing this condition.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Medicine

Background:

  • Chronic hepatitis B is a significant global health concern.
  • Understanding its natural history is crucial for effective patient management.
  • Long-term outcomes and prognostic factors require detailed investigation.

Purpose of the Study:

  • To elucidate the natural history of chronic hepatitis B.
  • To evaluate the long-term therapeutic outcomes in patients with chronic hepatitis B.
  • To assess the efficacy of antiviral drugs and identify prognostic factors.

Main Methods:

  • Retrospective follow-up of 183 biopsy-proven chronic hepatitis B patients and 247 controls over approximately 12 years.
  • Assessment of long-term clinical outcomes including liver cirrhosis, hepatocellular carcinoma (HCC), and mortality.
  • Statistical analysis, including Cox regression, to identify prognostic factors.

Main Results:

  • Chronic hepatitis B patients showed significantly higher rates of cirrhosis (12.02%), HCC (6.56%), and death (10.93%) compared to controls.
  • The 15-year survival rate was 84.47%, with a 15-year HCC incidence of 11.56%.
  • Old age, severe histological injury, positive HBeAg, and male gender were associated with adverse outcomes.

Conclusions:

  • The long-term prognosis for patients with chronic hepatitis B is poor.
  • Antiviral drug efficacy requires further comprehensive evaluation.
  • Identifying prognostic factors aids in risk stratification and management strategies.
Abstract

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...